Logo image of RZLV

REZOLVE AI PLC (RZLV) Stock Fundamental Analysis

NASDAQ:RZLV - Nasdaq - GB00BQH8G337 - Common Stock - Currency: USD

2.93  0 (0%)

After market: 2.95 +0.02 (+0.68%)

Fundamental Rating

1

RZLV gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 281 industry peers in the Software industry. Both the profitability and financial health of RZLV have multiple concerns. RZLV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RZLV had negative earnings in the past year.
In the past year RZLV has reported a negative cash flow from operations.
In the past 5 years RZLV always reported negative net income.
RZLV had a negative operating cash flow in each of the past 5 years.
RZLV Yearly Net Income VS EBIT VS OCF VS FCFRZLV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

RZLV has a Return On Assets of -872.47%. This is amonst the worse of the industry: RZLV underperforms 98.22% of its industry peers.
Industry RankSector Rank
ROA -872.47%
ROE N/A
ROIC N/A
ROA(3y)-292.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RZLV Yearly ROA, ROE, ROICRZLV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

RZLV has a better Gross Margin (81.84%) than 87.90% of its industry peers.
RZLV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RZLV Yearly Profit, Operating, Gross MarginsRZLV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K

More info and screens

0

2. Health

2.1 Basic Checks

RZLV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RZLV has been increased compared to 1 year ago.
The debt/assets ratio for RZLV is higher compared to a year ago.
RZLV Yearly Shares OutstandingRZLV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M 200M
RZLV Yearly Total Debt VS Total AssetsRZLV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

RZLV has an Altman-Z score of -34.73. This is a bad value and indicates that RZLV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -34.73, RZLV is doing worse than 95.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -34.73
ROIC/WACCN/A
WACC9.83%
RZLV Yearly LT Debt VS Equity VS FCFRZLV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.23 indicates that RZLV may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.23, RZLV is doing worse than 96.44% of the companies in the same industry.
A Quick Ratio of 0.23 indicates that RZLV may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.23, RZLV is doing worse than 96.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.23
RZLV Yearly Current Assets VS Current LiabilitesRZLV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

2

3. Growth

3.1 Past

RZLV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2570.28%.
EPS 1Y (TTM)-2570.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-493.89%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%29.43%

3.2 Future

The Earnings Per Share is expected to decrease by -38.87% on average over the next years. This is quite bad
Based on estimates for the next years, RZLV will show a very strong growth in Revenue. The Revenue will grow by 1864.27% on average per year.
EPS Next Y-183.33%
EPS Next 2Y-38.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14112.7%
Revenue Next 2Y1864.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

RZLV Yearly Revenue VS EstimatesRZLV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 20M 40M 60M 80M 100M
RZLV Yearly EPS VS EstimatesRZLV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RZLV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RZLV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RZLV Price Earnings VS Forward Price EarningsRZLV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RZLV Per share dataRZLV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

A cheap valuation may be justified as RZLV's earnings are expected to decrease with -38.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-38.87%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RZLV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REZOLVE AI PLC

NASDAQ:RZLV (8/1/2025, 8:01:31 PM)

After market: 2.95 +0.02 (+0.68%)

2.93

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-24 2025-04-24
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap713.95M
Analysts81.82
Price Target5.76 (96.59%)
Short Float %8.66%
Short Ratio1.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)-20.61%
EPS NY rev (3m)-51.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)5.14%
Revenue NY rev (3m)9.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3801.67
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS-0.16
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -872.47%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.84%
FCFM N/A
ROA(3y)-292.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1566.18%
Cap/Sales 1878.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.23
Altman-Z -34.73
F-Score5
WACC9.83%
ROIC/WACCN/A
Cap/Depr(3y)772.08%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2570.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-493.89%
EPS Next Y-183.33%
EPS Next 2Y-38.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%29.43%
Revenue Next Year14112.7%
Revenue Next 2Y1864.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4849.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1253.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1063.59%
OCF growth 3YN/A
OCF growth 5YN/A